Emerging Therapeutics Group
PrivateLast Round
VC Round
Apr 1, 2018
Company Overview
Emerging Therapeutics Group is a healthcare services company that operates a network of clinics specializing in natural medicine and medicinal cannabis consultations in Australia.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Compliance
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emerging Therapeutics Group Comparables
Compare Emerging Therapeutics Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Compass Lifestyle Clinic | 96% | |
| Canwell Australia | 93% | |
| Medifarm | 92% |
Emerging Therapeutics Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2018 |
Emerging Therapeutics Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Emerging Therapeutics Group's valuation, stock price, and market status.
Is Emerging Therapeutics Group a public or private company?
Emerging Therapeutics Group is a private company.
What is the current stock price of Emerging Therapeutics Group?
Emerging Therapeutics Group is a private company, so its shares have no public market price. Caplight tracks Emerging Therapeutics Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emerging Therapeutics Group worth (valuation)?
Valuation information for Emerging Therapeutics Group is not publicly available.
Can I buy Emerging Therapeutics Group stock?
Emerging Therapeutics Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emerging Therapeutics Group's last funding round?
Emerging Therapeutics Group's most recent funding round was VC Round on April 1, 2018.
Who are the main investors in Emerging Therapeutics Group?
Investor information for Emerging Therapeutics Group is not publicly disclosed.
Will Emerging Therapeutics Group IPO soon?
No public IPO plans have been announced for Emerging Therapeutics Group.
How can I track Emerging Therapeutics Group secondary market activity?
Caplight tracks bids, offers, and trades in Emerging Therapeutics Group's shares on secondary markets.